Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0016053 (fibromyalgia)
 4,687 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The frequency and significance of associated diseases and clinical problems in patients with nerve injuries in the recovery stage was statistically assessed. A variety of clinical situations are observed in practically all such patients. Half of the symptoms and diseases encountered relate to the nervous system and cardiocirculatory apparatus, while there is also a high incidence of skeletal muscle and urinary affections. The significance of these signs as far as rehabilitation is concerned can be seen in the fact that psychological and micturition disturbances are observed, along with muscle hypertonia, fibromyositis, cystitis and arthrosis. These form the more common obstacles to the regular execution of a rehabilitation programme, whereas no such significance is possessed by such serious diseases as valvular cardiopathy, hypertension and neoplasia of the neuraxis.
 ...
PMID:[Clinical problems of neural lesions in the phase of rehabilitation. Their significance and importance in final success of rehabilitation therapy]. 95 Oct 35

The post-transcriptional regulator molecules, microRNAs, have emerged as important biomarkers and modulators of numerous pathophysiological processes including oncogenesis and cardiovascular diseases. Recently, a significant number of dysregulations in microRNAs have been reported in patients suffering from painful disorders such as complex regional pain syndrome, cystitis-induced chronic pain and irritable bowel disorder, in both affected tissues and the circulation. Moreover, microRNAs are known to be involved in pain processing based on several recent findings in animal models of inflammatory and neuropathic pain. The basis of this review was to cover and summarize available articles in English encompassing "microRNA and pain". In animal pain models widespread microRNA modulation is present and manifests on multiple levels i.e.: the dorsal root ganglia, the spinal dorsal horn and the brain. Numerous functional in vivo studies have found that dysregulated microRNAs are involved in the post-transcriptional modulation of genes implicated in pain generation and maintenance. Lastly, a few animal studies have delivered promising results as to the possibility of applying microRNAs as therapeutics to alleviate established pain and several clinical studies have highlighted the potential in applying microRNAs as biomarkers in painful conditions such as complex regional pain syndrome and fibromyalgia. This review briefly introduces the basics of microRNAs, their biogenesis and function, and mainly focuses on the recent advances made in understanding the role of microRNAs in relation to pain processing and painful conditions. It also provides an overview of widely diverse methodological approaches and results with a potential for future implications of microRNAs in the diagnosis and treatment of pain.
...
PMID:MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions. 2511 78